Goodwin Procter advised BridgeBio Pharma, Inc. on the deal. BridgeBio Pharma, Inc. (Nasdaq: BBIO) announced its exclusive license agreement wit Bristol Myers Squibb to develop and...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Capital Bay Group on the deal. Capital Bay Group announced the formation of a joint venture with UAE-based Gulf Islamic Investments LLC. Under the...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP, Blomstein, Neuland, Houthoff, Metis and Homburger advised Qell Acquisition Corp. on the deal, while Hengeler Mueller advised Tencent on the transaction. Milbank LLP...
You must be a Standard 1 Year member to access this content.
